Therapeuticsmd Inc
(TXMD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -54,217 | -28,419 | -35,120 | -12,913 | N/A |
| Depreciation Amortization | 313 | 2,613 | 1,661 | 110 | N/A |
| Accounts receivable | -458 | -1,069 | -728 | -16 | N/A |
| Accounts payable and accrued liabilities | 4,213 | 473 | 1,335 | 189 | N/A |
| Other Working Capital | 3,419 | 1,207 | 1,406 | 450 | N/A |
| Other Operating Activity | 1,210 | 4,427 | 18,710 | 7,215 | 0 |
| Operating Cash Flow | $-45,521 | $-20,768 | $-12,737 | $-4,967 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -31 | -41 | -66 | -29 | N/A |
| Purchase Sale Intangibles | -587 | -439 | -206 | -9 | N/A |
| Other Investing Activity | -576 | -543 | -206 | -9 | 0 |
| Investing Cash Flow | $-607 | $-584 | $-273 | $-38 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 500 | 8,500 | 3,284 | N/A |
| Debt Repayment | N/A | -5,192 | -2,150 | -200 | N/A |
| Common Stock Issued | 43,298 | 78,681 | 8,087 | 1,724 | N/A |
| Other Financing Activity | 0 | 0 | 0 | -101 | 0 |
| Financing Cash Flow | $43,298 | $73,989 | $14,437 | $4,708 | $N/A |
| Beginning Cash Position | 54,191 | 1,554 | 126 | 423 | N/A |
| End Cash Position | 51,362 | 54,191 | 1,554 | 126 | N/A |
| Net Cash Flow | $-2,830 | $52,638 | $1,427 | $-297 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -45,521 | -20,768 | -12,737 | -4,967 | N/A |
| Capital Expenditure | -31 | -41 | -66 | -29 | N/A |
| Free Cash Flow | -45,552 | -20,809 | -12,804 | -4,995 | 0 |